From: Antimalarial drug use in general populations of tropical Africa
Variables | N | CQ+* | Prevalence of CQ † % | Crude OR | 95%CI | p‡ | Adjusted OR | 95%CI | p‡ | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Age | |||||||||||
2–5 years old | 1419 | 691 | 49 | 1.00 | 1.00 | ||||||
6–9 years old | 1633 | 571 | 35 | 0.74 | 0.09 | 0.63 | 0.001 | 0.76 | 0.64 | 0.90 | 0.002 |
Fever during the preceding 3 days | |||||||||||
without | 2252 | 852 | 38 | 1.00 | 1.00 | ||||||
with | 800 | 410 | 51 | 1.24 | 1.02 | 1.50 | 0.032 | 1.22 | 1.01 | 1.49 | 0.043 |
Proportion of individuals who were living in an other locality one year before the study | |||||||||||
< 5% | 1424 | 471 | 33 | 1.00 | 1.00 | ||||||
>= 5% | 1628 | 791 | 49 | 2.29 | 0.97 | 5.40 | 0.058 | 2.53 | 1.38 | 4.64 | 0.003 |
Score in 2 classes representing the households' average socioeconomic level | |||||||||||
< 6 | 2540 | 914 | 36 | 1.00 | 1.00 | ||||||
>= 6 | 512 | 349 | 68 | 4.73 | 1.74 | 12.87 | 0.002 | 2.74 | 1.11 | 6.78 | 0.029 |
Prevalence rate of the anti-CSP antibodies | |||||||||||
< 20% | 635 | 245 | 39 | 1.00 | 1.00 | ||||||
20–39.9% | 1227 | 746 | 61 | 2.82 | 1.11 | 7.16 | 0.0289 | 2.47 | 1.13 | 5.41 | 0.023 |
>= 40% | 1190 | 271 | 23 | 0.44 | 0.17 | 1.12 | 0.0885 | 0.68 | 0.32 | 1.43 | 0.305 |
Duration of the route to join the nearest tarmacked road | |||||||||||
< 1 hour | 1336 | 640 | 48 | 1.00 | 1.00 | ||||||
>= 1 hour | 1716 | 622 | 36 | 0.56 | 0.23 | 1.37 | 0.206 | 0.49 | 0.27 | 0.89 | 0.019 |